Hoosier Cancer Research Network highlights Bently Doonan, MD, MS, oncologist and assistant professor in the division of hematology & oncology at the university of Florida College of Medicine.

Hoosier Cancer Research Network highlights Sarah Sammons, MD a medical oncologist at Duke Cancer Center.

Hoosier Cancer Research Network highlights Richard Hall, MD, MS, a medical oncologist at University of Virginia Cancer Center. Dr. Hall is a member of the HCRN Thoracic Clinical Trial Working Group. Read More

Hoosier Cancer Research Network highlights Pashtoon Kasi, MD, MS, a medical oncologist at Weil Cornell Medicine. Dr. Kasi is a member of the HCRN Gastrointestinal Clinical Trial Working Group. Read More

This month, Hoosier Cancer Research Network highlights University of Washington (UW) / Fred Hutchinson Cancer Research Center and Petros Grivas, MD, PhD, a board-certified medical oncologist with expertise and experience in treating genitourinary (GU) cancers. In 2018, Dr. Grivas joined UW School of Medicine as an associate professor in the Department of Medicine and Clinical Director of the Genitourinary Cancers Program at UW and Fred Hutchinson Cancer Center. Read More

This month, Hoosier Cancer Research Network highlights Rana R. McKay, MD, a medical oncologist and researcher at UC San Diego Health. Dr. McKay specializes in treating people with urogenital cancers, including bladder, kidney, prostate, and testicular cancers, and leads a multi-disciplinary prostate cancer clinic. As an associate professor in the Department of Medicine, Dr. McKay instructs medical students, residents, and fellows at UC San Diego School of Medicine. She is a co-chair of HCRN’s Genitourinary Clinical Trial Working Group. Read More

This month, Hoosier Cancer Research Network highlights Winship Cancer Institute of Emory University and Mylin Torres, MD, professor in the Department of Radiation Oncology, Emory University School of Medicine. Currently, Dr. Torres serves as co-leader of the Cancer Prevention and Control research program at Winship Cancer Institute while also serving as a radiation oncologist at the cancer center.

She is a member of HCRN’s Breast Cancer Clinical Trial Working Group and sponsor-investigator of HCRN BRE19-433, a multi-institutional Phase II study to evaluate efficacy and safety of TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 negative Patients with PD-L1+ Metastatic Triple Negative Breast Cancer (TARA). Read More

This month, Hoosier Cancer Research Network features Andrew S. Poklepovic, MD, in our investigator spotlight. Dr. Poklepovic serves as assistant professor in the Division of Hematology, Oncology and Palliative Care at the VCU Massey Cancer Center and is a Harrison Endowed Scholar at the VCU School of Medicine. He is also the medical director for the Massey Cancer Center Clinical Trials Office and an associate member of the Massey Cancer Center Developmental Therapeutics Program for the Department of Internal Medicine.

Read More

This month, Hoosier Cancer Research Network features our member institution University of Rochester Medical Center – Wilmot Cancer Institute and Ruth O’Regan, MD, the Charles A. Dewey Professor and Chair of Medicine at the University of Rochester Medical Center’s School of Medicine and Dentistry.

Dr. O’Regan is a medical oncologist with more than 25 years of experience in academic medicine. Her research interests are significantly focused on identifying mechanisms of resistance to breast cancer therapies, specifically endocrine-resistant and triple-negative breast cancers.

Read More

This month, Hoosier Cancer Research Network features our member institution Rutgers Cancer Institute of New Jersey and Coral Omene, MD, PhD, medical oncologist at Rutgers Cancer Institute and Assistant Professor of Medicine at Rutgers Robert Wood Johnson Medical School.

Research Interests and Expertise:

Dr. Omene is a medical oncologist with a passion for women’s health who is dedicated to the care of treating and managing a diverse pool of breast cancer patients. She has devoted much of her research toward translating novel laboratory observations into discoveries to better care for breast cancer patients, with a particular focus on triple negative breast cancer (TNBC), which is known to be among the most aggressive breast cancers, with a poor prognosis, especially among African American women.

Read More

This month, Hoosier Cancer Research Network features our member institution UT Southwestern Harold C. Simmons Comprehensive Cancer Center in Dallas, Texas, and Hans Hammers, MD, PhD, an associate professor of internal medicine in the Division of Hematology and Oncology at the UT Southwestern Medical School and the first Eugene P. Frenkel, M.D. Scholar in Clinical Medicine.

Read More

This month, Hoosier Cancer Research Network features our member institution Summit Health Cancer Center in Florham Park, New Jersey, and David Gallinson, DO, a medical oncologist.

Read More

This month, Hoosier Cancer Research Network features our member institution Fox Chase Cancer Center, and Daniel M. Geynisman, MD, associate professor, Hematology/Oncology and a medical oncologist at Fox Chase Cancer Center.

Read More

This month, Hoosier Cancer Research Network features our member institution University of North Carolina Lineberger Comprehensive Cancer Center and Joshua F. Zeidner, MD, associate professor of medicine, chief of leukemia research, and associate chief of research, hematology at UNC Lineberger.

Read More

This month, Hoosier Cancer Research Network features our member institution Froedtert & the Medical College of Wisconsin in Milwaukee, Wis., and Deepak Kilari, MD, a medical oncologist with specialization in genitourinary cancers.

Read More

This month, Hoosier Cancer Research Network features our member institution Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Mo., and Jian Li Campian, MD, PhD, a medical oncologist with specialization in neuro-oncology and immunotherapy.

Read More

This month, Hoosier Cancer Research Network features our member institution Cleveland Clinic Cancer Center and medical oncologist Shilpa Gupta, MD. Dr. Gupta is a genitourinary oncologist and the leader of the bladder cancer program at the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio. She is also a member and co-chair elect of Hoosier Cancer Research Network’s Genitourinary Clinical Trial Working Group. Read More

This month, Hoosier Cancer Research Network features our member institution The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and medical oncologist Dwight Owen, MD, MS. Dr. Owen is a member of the Translational Therapeutics Program at the OSUCCC – James.

Read More

This month, Hoosier Cancer Research Network features our member institution Vanderbilt-Ingram Cancer Center (VICC) in Nashville, Tenn., and Nancy B. Davis, MD, associate professor of medicine and VICC senior medical director for Cancer Care Network and Strategy, Division of Hematology/Oncology, Vanderbilt University Medical Center. Read More

This month, Hoosier Cancer Research Network features our member institution, the University of Michigan Rogel Cancer Center, and Ulka Nitin Vaishampayan, MBBS, FAB, director of the phase I program at Rogel Cancer Center and a professor of internal medicine at the University of Michigan Medical School. Dr. Vaishampayan is leading an HCRN multi-institution study that will investigate pembrolizumab and lenvatinib in advanced/metastatic neuroendocrine prostate cancer. She is a site principal investigator on HCRN bladder cancer studies GU14-182 and GU15-262, and a co-investigator on the Big Ten Cancer Research Consortium kidney cancer study BTCRC-GU16-043. She is a member of the HCRN Genitourinary Clinical Trial Working Group. Read More